RespireRx Pharmaceuticals Inc (fka RSPI)

[gfp927z]

Athero, Concerning the supply, if BAM still has any shares left from the preferred conversion (probably not many, if any), their overall cost basis is in the .17 range. The supply we're seeing probably won't be from BAM much longer, and they may already be gone (Jerry may have some thoughts on this).

BAM's 6.9 mil warrants do become exercisable ~Oct 17, so these could then come online, but they are exercisable at .34, so shouldn't be a factor until we get above that level. R+R also has some warrants (433 K) priced at .26, which I think can come online Oct 17 also.

The supply right now is probably coming from nervous nellies like me :o) I'll kind of miss the BAM supply in a way since it made it easy to enter a large position at any time. You could just hit their ask and get all you wanted.